ATOSSA THERAPEUTICS, INC. — Director's Dealing 2015

Sep 4, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ATOSSA GENETICS INC (ATOS)
CIK: 0001488039
Period of Report: 2015-09-01

Reporting Person: Youmans Scott (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-01	Stock Option (right to buy)	$0.76	A	50000	Acquired	2025-09-01	Common Stock (50000)	Direct

Footnotes

F1: The stock option will vest on a quarterly basis over the next 48 months.